Pomanda estimates the enterprise value of AURUM PHARMACEUTICALS LIMITED at £493.6k based on a Turnover of £917k and 0.54x industry multiple (adjusted for size and gross margin).
aurum pharmaceuticals limitedEstimated Valuation
£78.6k
Pomanda estimates the enterprise value of AURUM PHARMACEUTICALS LIMITED at £78.6k based on an EBITDA of £27.5k and a 2.86x industry multiple (adjusted for size and gross margin).
aurum pharmaceuticals limitedEstimated Valuation
£42.6k
Pomanda estimates the enterprise value of AURUM PHARMACEUTICALS LIMITED at £42.6k based on Net Assets of £27.6k and 1.54x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Aurum Pharmaceuticals LimitedOverview
Aurum Pharmaceuticals Limited is a live company located in essex, RM3 8UG with a Companies House number of 02581060. It operates in the manufacture of basic pharmaceutical products sector, SIC Code 21100. Founded in February 1991, it's largest shareholder is
orphea limited
with a 100% stake. Aurum Pharmaceuticals Limited is a mature,
small sized company, Pomanda has estimated its turnover at
£917k with
unknown
growth in recent years.
Pomanda's financial health check has awarded Aurum Pharmaceuticals Limited a 0.5 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 7 areas for improvement. Company Health Check FAQs
Health Rating0.5out of 5
0 Strong
1 Regular
7 Weak
Size
annual sales of £917k, make it smaller than the average company (£20.2m)
£917k - Aurum Pharmaceuticals Limited
£20.2m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- - Aurum Pharmaceuticals Limited
- - Industry AVG
Production
with a gross margin of 5.9%, this company has a higher cost of product (37.1%)
5.9% - Aurum Pharmaceuticals Limited
37.1% - Industry AVG
Profitability
an operating margin of 3% make it less profitable than the average company (5.9%)
3% - Aurum Pharmaceuticals Limited
5.9% - Industry AVG
Employees
with 3 employees, this is below the industry average (76)
3 - Aurum Pharmaceuticals Limited
76 - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- - Aurum Pharmaceuticals Limited
- - Industry AVG
Efficiency
resulting in sales per employee of £305.7k, this is equally as efficient (£300k)
£305.7k - Aurum Pharmaceuticals Limited
£300k - Industry AVG
Debtor Days
it gets paid by customers after 438 days, this is later than average (48 days)
438 days - Aurum Pharmaceuticals Limited
48 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Aurum Pharmaceuticals Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Aurum Pharmaceuticals Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 0 weeks, this is less cash available to meet short term requirements (21 weeks)
0 weeks - Aurum Pharmaceuticals Limited
21 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 97.5%, this is a higher level of debt than the average (46.4%)
97.5% - Aurum Pharmaceuticals Limited
46.4% - Industry AVG
AURUM PHARMACEUTICALS LIMITED financials
EXPORT
Aurum Pharmaceuticals Limited's latest turnover from December 2023 is £917 thousand and the company has net assets of £27.6 thousand. According to their latest financial statements, Aurum Pharmaceuticals Limited has 3 employees and maintains cash reserves of £286 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Jun 2016
Jun 2015
Jun 2014
Jun 2013
Jun 2012
Jun 2011
Jun 2010
Turnover
917,011
Other Income Or Grants
Cost Of Sales
863,107
Gross Profit
53,904
Admin Expenses
26,394
-1
Operating Profit
27,510
1
Interest Payable
Interest Receivable
Pre-Tax Profit
27,510
1
Tax
Profit After Tax
27,510
1
Dividends Paid
Retained Profit
27,510
1
Employee Costs
Number Of Employees
3
EBITDA*
27,510
1
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Jun 2016
Jun 2015
Jun 2014
Jun 2013
Jun 2012
Jun 2011
Jun 2010
Tangible Assets
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
Stock & work in progress
Trade Debtors
1,101,987
Group Debtors
103
103
103
103
Misc Debtors
Cash
286
misc current assets
total current assets
1,102,273
103
103
103
103
total assets
1,102,273
103
103
103
103
Bank overdraft
Bank loan
Trade Creditors
Group/Directors Accounts
863,290
other short term finances
hp & lease commitments
other current liabilities
211,370
total current liabilities
1,074,660
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
1,074,660
net assets
27,613
103
103
103
103
total shareholders funds
27,613
103
103
103
103
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Jun 2016
Jun 2015
Jun 2014
Jun 2013
Jun 2012
Jun 2011
Jun 2010
Operating Activities
Operating Profit
27,510
1
Depreciation
Amortisation
Tax
Stock
Debtors
1,101,884
103
Creditors
Accruals and Deferred Income
211,370
Deferred Taxes & Provisions
Cash flow from operations
-863,004
-102
Investing Activities
capital expenditure
Change in Investments
cash flow from investments
Financing Activities
Bank loans
Group/Directors Accounts
863,290
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
102
interest
cash flow from financing
863,290
102
cash and cash equivalents
cash
286
overdraft
change in cash
286
aurum pharmaceuticals limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for aurum pharmaceuticals limited. Get real-time insights into aurum pharmaceuticals limited's credit score, group structure and payment trends.
Perform a competitor analysis for aurum pharmaceuticals limited by selecting its closest rivals, whether from the MANUFACTURING sector, other small companies, companies in RM3 area or any other competitors across 12 key performance metrics.
aurum pharmaceuticals limited Ownership
AURUM PHARMACEUTICALS LIMITED group structure
Aurum Pharmaceuticals Limited has no subsidiary companies.
The sole shareholder of Aurum Pharmaceuticals Limited is Orphea Limited.
orphea limited
100%
aurum pharmaceuticals limited directors
Aurum Pharmaceuticals Limited currently has 3 directors.
The longest serving directors include
Mr Bruno De Ultra De Sousa Barcelos (Jan 2023) and
Mr Xavier Lasserre (Jun 2023).
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023
net assets
27.6k
+267.09%
total assets
1.1m
+10700.68%
cash
286
0%
net assets
Total assets minus all liabilities
Similar Companies
Similar companies unavailable for this selection
aurum pharmaceuticals limited company details
company number
02581060
Type
Private limited with Share Capital
industry
74990 - Non-trading company
21100 - Manufacture of basic pharmaceutical products
incorporation date
February 1991
age
34
incorporated
UK
ultimate parent company
FINANCIERE VERDI III
accounts
Full Accounts
last accounts submitted
December 2023
previous names
alger limited (July 1991)
accountant
-
auditor
GRANT THORNTON UK LLP
address
bampton road, romford, essex, RM3 8UG
Bank
-
Legal Advisor
-
aurum pharmaceuticals limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 7 charges/mortgages relating to aurum pharmaceuticals limited. Currently there are 0 open charges and 7 have been satisfied in the past.
aurum pharmaceuticals limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for AURUM PHARMACEUTICALS LIMITED. This can take several minutes, an email will notify you when this has completed.
aurum pharmaceuticals limitedCompanies House Filings - See Documents
